The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial

被引:4
|
作者
Li, Wei [1 ]
Zhao, Jun [1 ]
Hao, Ruiping [1 ]
Wang, Shujuan [1 ]
Chen, Ming [1 ]
Liu, Huijun [1 ]
Qi, Le [1 ]
Hao, Zaijun [1 ,2 ]
机构
[1] Ordos Cent Hosp, Dept Anaesthesiol, Ordos, Inner Mongolia, Peoples R China
[2] Ordos Cent Hosp, Dept Anesthesiol, Ordos 017000, Inner Mongolia, Peoples R China
来源
关键词
remimazolam besylate; propofol; esketamine; colonoscopy; PROPOFOL SEDATION; ANESTHESIA; KETAMINE; DISORDERS; INDEX;
D O I
10.2147/DDDT.S425860
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purpose: Evaluate the efficacy and safety of remimazolam besylate combined with esketamine for outpatient colonoscopy.Patients and methods: A total of 150 outpatients undergoing colonoscopy were randomized into two groups. A MOAA/S score <= 3 was maintained. The primary outcome was the rate of successful colonoscopy completion. Time indicators, hemodynamic parameters, the consumption of lidocaine, esketamine, propofol and remimazolam besylate, MOAA/S scores and bispectral index (BIS) values, the lowest SpO(2), body movement, the use of rescue medication, endoscopist and patient satisfaction, recall of the procedure, mini-mental state examination (MMSE), fatigue level and adverse events were recorded.Results: Procedure completion was equivalent between groups (P > 0.05). Both induction and awakening times were significantly shorter in the P group (P < 0.05). There were no significant differences in colonoscopy time and discharge time (P > 0.05). The lowest SpO(2) was significantly lower in the P group, while the level of fatigue was higher (P < 0.05). Patient satisfaction was significantly higher in the R group (P < 0.05). Endoscopist satisfaction was significantly higher in the P group (P < 0.05). There were no significant differences in both systolic and diastolic blood pressure between groups except at T5 and T6 (P > 0.05). Both HR and RR were significantly lower in the P group from T3 to T5 (P < 0.05). BIS values were significantly lower in the P group from T3 to T5, while MOAA/S was significantly lower in the P group at T3 and T4 (P < 0.05). Pain on injection was significantly higher in the P group (P < 0.05).Conclusion: Remimazolam besylate has a similar efficacy to propofol when combined with subanesthetic doses of esketamine during outpatient colonoscopy. Remimazolam besylate combined with esketamine resulted in less injection pain and more stable hemodynamics, although it prolonged induction and awakening time.
引用
收藏
页码:2875 / 2887
页数:13
相关论文
共 50 条
  • [41] The safety and efficacy of nalbuphine in laparoscopic cholecystectomy: A prospective randomized controlled trial
    Cao, Shuang-jiao
    Wu, Wei-wei
    Zhang, Wei-yi
    Zhu, Tao
    ASIAN JOURNAL OF SURGERY, 2022, 45 (08) : 1561 - 1564
  • [42] Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial
    Marija Pesic
    Frank Schippers
    Rob Saunders
    Lyn Webster
    Martin Donsbach
    Thomas Stoehr
    European Journal of Clinical Pharmacology, 2020, 76 : 1505 - 1516
  • [43] Comparative efficacy and safety of nalbuphine and hydromorphone in painless colonoscopy techniques: a randomized controlled trial
    Chunliu Hou
    Siming Zhang
    Yuqing Zhu
    Guochun Wen
    Guoran Wang
    Jinxiang Dai
    Fei Xu
    Chunjie Li
    Huiyi Chen
    Di Wang
    Qingqing Han
    Xuesen Su
    Wenjie Zhang
    Shouyuan Tian
    Yan Li
    BMC Anesthesiology, 25 (1)
  • [44] Safety and efficacy of remimazolam for general anesthesia in elderly patients undergoing laparoscopic cholecystectomy: a randomized controlled trial
    So, Keum Young
    Park, Jihwan
    Kim, Sang Hun
    FRONTIERS IN MEDICINE, 2023, 10
  • [45] A prospective, open-label, randomized clinical trial to evaluate the efficacy and safety of remimazolam in patients undergoing EBUS-TBNA: REST trial design
    Seol, Hee Yun
    Hong, Kyung Soo
    Jang, Jong Geol
    Moon, Seong Mi
    Kim, Sun-Hyung
    Cho, Jun Yeun
    Yang, Bumhee
    Kim, Seonok
    Choi, Chang-Min
    Ji, Wonjun
    Ahn, June Hong
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [46] Remimazolam versus propofol in combination with esketamine for surgical abortion: A double-blind randomized controlled trial
    Yue, Linli
    Ma, Xiaoling
    Li, Na
    Chen, Jing
    Wang, Jun
    Wan, Zhenzhen
    Yang, Lin
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (09): : 1606 - 1616
  • [47] The efficacy and safety of patient-controlled intravenous analgesia with esketamine after total hip arthroplasty: a randomized controlled trial
    Qu, Song
    Zhang, Wen-Jie
    Zhou, Hai-Jiao
    Deng, Fei
    Liu, Rui-Juan
    Yan, Wen-Jun
    BMC ANESTHESIOLOGY, 2025, 25 (01):
  • [48] A blinded, randomized, prospective trial comparing three preparations for outpatient colonoscopy
    Kiyici, N
    Jayadevan, R
    Ricci, M
    Nayak, T
    Norkus, E
    Hertan, H
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S107 - S108
  • [49] Efficacy and safety of remimazolam for sedation during endoscopic procedures in Japanese: A prospective phase III clinical trial
    Ikehara, Hisatomo
    Ichijima, Ryoji
    Takeuchi, Yoji
    Kanazawa, Jun
    Wada, Takuya
    Okuwaki, Kosuke
    Ueda, Tomoya
    Kogure, Hirofumi
    Kusano, Chika
    Ono, Hiroyuki
    DIGESTIVE ENDOSCOPY, 2025,
  • [50] Efficacy of an outpatient treatment for prolonged grief disorder: A randomized controlled clinical trial
    Rosner, Rita
    Pfoh, Gabriele
    Kotoucova, Michaela
    Hagl, Maria
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 167 : 56 - 63